Promore Pharma is granted a patent for LL-37 in Japan
2019-08-27
STOCKHOLM, 27 August 2019 – Promore Pharma AB, a Swedish biopharmaceutical developer of therapeutic peptides, today announced that the company was granted a patent in Japan for the usage of LL-37 for treating chronic wounds.
Läs hela meddelandet på Promore Pharmas hemsida.
Läs mer..